NCT06475820 2024-08-23Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Baricitinib at Children and Young Adults With HemoblastosisFederal Research Institute of Pediatric Hematology, Oncology and ImmunologyPhase 2/3 Active not recruiting150 enrolled